MedPath

Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control

Completed
Conditions
Coronary Artery Disease
Diabetes
Registration Number
NCT03338153
Lead Sponsor
Tehran Heart Center
Brief Summary

the purpose of this study is to determine whether appropriate control of diabetes around the PCI time is related with MACE and outcome of diabetic patients.

Detailed Description

Despite recent advances in coronary revascularization, cardiovascular disease accounts for about 75% of all hospital admissions in diabetic patients.although the introduction of drug-eluting stents has reduced the rates of restenosis after PCI, diabetic patients undergoing PCI will have poorer clinical outcomes.In this study, we sought to investigate whether a pre and post procedural glycemic control in diabetic patients,as reflected by HgbA1C prior,1 and 6 months after elective PCI,was related to major advance cardiac events (MACE) during 3 year follow up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1353
Inclusion Criteria
  • age between 18-75
  • coronary stenosis > 70%
Exclusion Criteria
  • Myocardial infarction in 72 hours prior to PCI
  • LVEF < 30%
  • Residual Stenosis>30%
  • Cr level > 2.0
  • hemodynamic compromise during intervention
  • Left main lesions
  • PCI for vein grafts

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major adverse cardiac eventduring 3 years after per-cutaneous coronary intervention
Secondary Outcome Measures
NameTimeMethod
target vessel revascularizationduring 3 years after PCI
target lesion revascularizationduring 3 years after PCI

Trial Locations

Locations (1)

Tehran heart center, Tehran university of medical sciences

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath